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Introduction INVESTIGATIONS 
Pulmonary veno-occlusive disease (PVOD) is an uncom- 
mon cause of pulmonary hypertension. There are reports of 
PVOD occurring in patients with recognized autoimmune 
diseases, and in patients with serological evidence of 
autoimmune disturbance. We report a case of PVOD 
occurring in association with the Felty’s syndrome variant 
of rheumatoid arthritis. 
Case Report 
36-year-old woman was admitted with 2 days of extreme 
breathlessness superimposed on 2 months of worsening 
effort dyspnoea, and a year of increasing ankle oedema. She 
had a 16-year history of the Felty’s variant of severe 
rheumatoid arthritis (rheumatoid factor <l in 320). She 
had received disease modifying therapies: penicillamine, 
intramuscular gold and salazopyrine, which were discon- 
tinued after 5-13 months, because of ineffectiveness or 
side-effects. For 5 years she was maintained on hydroxy- 
chloroquine which was discontinued at the age of 33, and 
her arthritis had been quiescent since. A premature meno- 
pause led to endocrinological investigation and a diagnosis 
of partial hypopituitarism. Admission medication was 
hormone replacement, thyroxine and aspirin for analgesia. 
She had never smoked and there was no relevant occupa- 
tional or animal exposure. Examination revealed rheuma- 
toid deformities, blood pressure 90/60 mmHg, jugular 
venous pressure elevated by 5 cm with cv waves, precordial 
auscultation revealed a pansystolic murmur at the left 
sternal edge. There was bilateral pitting oedema. Chest 
examination revealed bilateral pleural effusions, with basal 
crepitations. There was 6 cm splenomegaly. 
ECG sinus rhythm, right axis deviation. Blood gas analysis 
(breathing air), pH 7.37, PaO, 7.75 kPa, PaCO, 2.51 kPa, 
haemoglobin 9.8 g dl - ’ microcytic, leukocytes 0.9 x log/l, 
neutrophils 0.2 x 109/1. Coagulation screen within normal 
limits. Positive autoantibodies: homogeneous antinuclear (1 
in 640) and antismooth muscle. Pleural aspirate: protein 
22g1-‘, no malignant cells or organisms. Chest radio- 
graph: normal heart size, bilateral pleural effusions. Venti- 
lation perfusion scan: no ventilation perfusion mismatch. 
High resolution computed tomography (CT) scan: bilateral 
pleural effusions, no interstitial fibrosis. Pulmonary func- 
tion (normal 3 years previously): FEV, 0.91 (predicted 2.9) 
FVC 1.1 1 (3.6), FEV,/FVC 82%, FRC 1.5 1 (3.2), RV 0.9 1 
(1.6), TLC 2.3 1 (5.2). Echocardiogram: normal left ven- 
tricular function, dilated right atrium and ventricle with 
tricuspid regurgitation, elevated pulmonary arterial pres- 
sure. Cardiac catheterization; normal left ventricular and 
coronary angiograms, pulmonary artery pressure 66/33 
(mean 45) mmHg, mean pulmonary wedge 11 mmHg, right 
ventricle 61/19 mmHg with no evidence of constrictive 
pericarditis. 
These investigations indicated moderately severe pul- 
monary hypertension with right heart failure. Diuretic 
therapy resulted in an improvement in symptoms, oedema 
and radiographic appearances. She subsequently deterio- 
rated, with worsening pulmonary hypertension (confirmed 
by echocardiography), and evidence of systemic vasculitis 
(nail bed infarcts and splinter haemorrhages). Treatment 
with methyl-prednisolone and cyclophosphamide was com- 
menced because of the suspicion of concomitant pulmonary 
vasculitis, however, she continued to deteriorate and died 
5 months after presentation. 
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At autopsy the heart weighed 350 g. The right ventricle 
was 0.7 cm thick and had a dissected weight of 130 g 
indicating hypertrophy. The right atrium and tricuspid 
valve ring were dilated. There were bilateral serous pleural 
effusions. Both lungs were heavy (right 865 g, left 778 g), 
and after inflation/fixation then section, showed patchy 
haemorrhage and irregular ‘geographical’ areas of necrosis. 
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PLATE 1. The thickened septum shows fibrosis, dilated 
lymphatics and two sections of almost obliterated pul- 
monary vein with evidence of recanalization. The lung to 
the left of the septum shows haemorrhagic infarction. 
Arterial emboli were absent. The liver (1820 g) and spleen 
(620 g) were enlarged and there was generalized lymph- 
adenopathy. Histological examination showed hepatic 
central venous congestion and associated parenchymal 
changes, splenic congestion and widespread reactive lym- 
phoid hyperplasia. Pulmonary changes were widespread, 
severe and complex. There was a background of usual 
interstitial pneumonitis with foci of diffuse alveolar damage 
(DAD). Diffuse fibrosis was evident. There was widespread 
venular obstruction with intimal fibrosis, organizing 
thrombi and recanalization, sometimes associated with 
small irregular paraseptal infarcts (Plate 1). Haemosiderosis 
was minimal and there was no evidence of thrombotic 
or plexogenic arteriopathy, or arteritis. A diagnosis of 
pulmonary veno-occlusive disease was made. 
Discussion 
Although this woman was limited by the rheumatoid arthri- 
tis of Felty’s syndrome, her condition was stable until she 
was afflicted by an aggressive illness which proved terminal 
7 months after the onset of dyspnoea. The clinical signs, 
investigations and autopsy indicated pulmonary hyperten- 
sion consequent upon PVOD with car pulmonale and 
impaired cardiac output. 
PVOD is an uncommon cause of pulmonary hyperten- 
sion, usually afflicting children and young adults with a 2: 1 
male predominance in adults (1). Although the condition 
can be rapidly fatal (2), mean survival is 20 months (3). 
Presentation is usually with dyspnoea, orthopnoea, hypox- 
aemia and right heart failure. The diagnosis should be 
suspected if there is the combination of pulmonary arterial 
hypertension with a normal pulmonary wedge pressure and 
evidence of pulmonary interstitial oedema; confirmation is 
by open lung biopsy or autopsy. The pathological features 
are as described above. Interstitial inflammation and even 
DAD are described in PVOD and do not necessarily infer a 
second disease, e.g. rheumatoid lung (4). 
The aetiology of PVOD is unknown but a proposed final 
common pathway is pulmonary arterial and venous intimal 
damage, thrombus formation and organization (1). Viral 
infections have been implicated (5,6). PVOD may be a 
response to exogenous toxins/drugs, most notably the cyto- 
toxic agents, carmustine, bleomycin, busulphan, mitomycin 
and the vinca alkaloids, but a case of PVOD has been 
attributed to inhalation of household cleanser (7). PVOD 
has been described in Hodgkin’s disease with or without 
radiotherapy and following bone marrow transplantation 
(89). Our case had received disease modifying agents for 
rheumatoid arthritis, however, these were discontinued 
before the onset of PVOD and we are unaware of any 
association between PVOD and these drugs. 
We are unaware of a reported association between 
PVOD and rheumatoid arthritis or Felty’s syndrome. 
Whilst our case may represent a chance coincident occur- 
rence, there is evidence that some cases of PVOD may have 
an autoimmune aetiology. PVOD has been associated with 
systemic lupus erythematosus and the CREST variant 
of scleroderma (10,ll) and there are reports suggesting 
autoimmune processes in PVOD: Katz described a case of 
PVOD with positive rheumatoid and antinuclear factors 
(12) Corrin demonstrated immune complex deposition in 
the alveoli of a case of PVOD (13), and a case of PVOD 
with positive antinuclear and negative rheumatoid factors 
has been described (14). The present case had historical 
evidence of positive rheumatoid factor, positive antinuclear 
factor on presentation and clinical evidence of vasculitis 
later in her disease. It is probable that this case of PVOD 
was an unusual manifestation of the auto-immune pro- 
cesses associated with Felty’s syndrome. 
Acknowledgement 
We are grateful to the late Professor C. A. Wagenvoort, 
Academic Hospital, Rotterdam, for confirming the diag- 
nosis in this case. 
References 
1. Wagenvoort CA, Wagenvoort N, Takahashi T. Pul- 
monary veno-occlusive disease. Involvement of pul- 
monary arteries and review of the literature. Human 
Puthol 1985; 16: 1033-1041. 
2. Nawaz S, Dobersen MJ, Blount SG, Firminger HI, 
Petty TL. Florid pulmonary veno-occlusive disease. 
Chest 1990; 98: 1037-1039. 
3. Cohn RC, Wong R, Spohn WA, Komer M. Death 
due to diffuse alveolar haemorrhage in a child with 
pulmonary veno-occlusive disease. Chest 1991; 100: 
145661458. 
4. Wagenvoort CA, Mooi WJ. Biopsy Pathology of the 
Pulmonary Vasculature. Chapter 11, 199-2 16. London: 
Chapman and Hall, 1989. 
5. McDonnell PJ, Summer WR, Hutchins GM. Pulmon- 
ary veno-occlusive disease. Morphological changes 
CASE REPORTS 1091 
suggesting a viral cause. J Am Med Assoc 1972; 246: 
667. 
6. Jacques C, Richmond G, Tierney L, Curtis JL, 
McKerrow J, Warnock ML. Primary pulmonary 
hypertension and human immunodeficiency virus 
infection in a non-haemophilic man. Hum Pathol 1992; 
23: 191-194. 
7. Liu L, Sackler JP. A case of pulmonary veno-occlusive 
disease. Aetiological and therapeutic appraisal. Angiol- 
ogy 1972; 23: 299. 
8. Swift GL, Gibbs A, Campbell IA, Wagenvoort CA, 
Tuthill D. Pulmonary veno-occlusive disease and 
Hodgkins lymphoma. Eur Resp J 1993; 6: 596. 
9. Morgan M, Dodds A, Atkinson K, Szer J, Downs K, 
Biggs J. The toxicity of busulphan and cyclophospha- 
mide as the preparative regimen for bone marrow 
transplantation. Br J Haematol 1991; 42: 529. 
10. Kishida Y, Kanai Y, Kuramochi S, Hasoda Y. Pul- 
monary veno-occlusive disease in a patient with sys- 
temic lupus erythematosus (SLE). J Rheumatol 1993; 
20: 2161-2162. 
11. Morassut PA, Walley VM, Smith CD. Pulmonary 
veno-occlusive disease and the CREST variant of 
scleroderma. Can J Cardiol 1992; 8: 105551058. 
12. Katz DS, Scalzetti EM, Katzenstein ALA, Kohman 
LJ. Pulmonary veno-occlusive disease presenting with 
thrombosis of pulmonary arteries. Thorax 1994; 50: 
699-700. 
13. Corrin B, Spencer H, Turner-Warwick M, Beales SJ, 
Hamblin JJ. Pulmonary veno-occlusion - an immune 
complex disease? Virchow Arch [Pathol Anat] 1974; 
364: 81-91. 
14. Case Records of the Massachusetts General Hospital 
(Case 141983). N Engl J Med 1983; 308: 823-833. 
